An interventional study of Ring Fit Adventure-based Exercise Program in Functional Decline, sponsored by Tungs' Taichung Metroharbour Hospital. Recruiting at 1 site in Taiwan. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-11-02.
Sponsored by Tungs' Taichung Metroharbour Hospital · Not applicable, Interventional, and Prevention
Falls and decline in physical function are common problems in community-dwelling older adults. Exercise programs may help improve balance, mobility, and physical function and may reduce fall risk.
This study aims to evaluate the effects and feasibility of an 8-week Ring Fit Adventure-based exercise program in community-dwelling older adults with functional decline and risk of falls. Eligible participants will be assigned to experimental and control groups and followed for 24 weeks.
The study will examine whether this exercise program can improve balance, physical function, and fall risk. Outcomes will be assessed at multiple time points, including before the intervention, after the intervention, and during follow-up.
Falls and functional decline are major health concerns among community-dwelling older adults. Reduced balance, decreased mobility, and lower physical performance may increase the risk of falls and loss of independence. Exercise-based interventions have been used to improve balance and physical function in older adults. Ring Fit Adventure is an interactive exercise program that combines game-based tasks with physical activity and may provide a feasible and engaging approach for this population.
The purpose of this study is to evaluate the effectiveness and feasibility of a Ring Fit Adventure-based exercise intervention for community-dwelling older adults with functional decline and fall risk.
This study will enroll 100 participants. Participants will undergo study assessments at baseline and follow-up time points. The intervention period is 8 weeks, and the total follow-up period is 24 weeks. Outcome assessments are planned at baseline (T0), post-intervention (T1), and follow-up time points (T2 and T3).
The study will evaluate changes in balance, physical function, and fall risk after participation in the intervention. The Brief-BESTest will be used as one of the main outcome measures. Additional outcome measures will be collected according to the study protocol.
The findings of this study may help determine whether a game-based exercise intervention is a practical and beneficial approach for improving function and reducing fall risk in community-dwelling older adults.
Tungs' Taichung Metroharbour Hospital is the lead sponsor of 24 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants in this arm will receive an 8-week AI-assisted movement classification using Ring Fit Adventure-based exercise intervention designed to improve balance, physical function, and fall risk in community-dwelling older adults.
Behavioral: Ring Fit Adventure-based Exercise Program
Participants in this arm will not receive the standard Ring Fit Adventure-based exercise intervention during the study period.
Participants will receive an 8-week Ring Fit Adventure-based exercise program designed for community-dwelling older adults. The intervention uses structured exergame-based physical activity to improve balance, physical function, and fall risk.
Balance performance measured by Brief-BESTest
Balance performance will be assessed using the Brief Balance Evaluation Systems Test (Brief-BESTest), which evaluates 6 domains of postural control. Each item is scored from 0 to 3, with a total score ranging from 0 to 24. Higher scores indicate better balance performance.
Time frame: Baseline, Week 8, Week 12, and Week 24
Cognitive function measured by Montreal Cognitive Assessment
Cognitive function will be assessed using the Montreal Cognitive Assessment (MoCA). The total score ranges from 0 to 30, with higher scores indicating better cognitive function.
Time frame: Baseline, Week 8, Week 12, and Week 24
Attendance rate
Attendance will be assessed as the number of completed intervention sessions out of the total planned sessions during the 8-week intervention period.
Time frame: During the 8-week intervention period
Adherence to the intervention
Adherence will be defined as attendance at at least 80% of the planned intervention sessions.
Time frame: During the 8-week intervention period
Completion rate
Completion will be assessed as the proportion of participants who complete the intervention program and follow-up assessments.
Time frame: Up to Week 24
Acceptability measured by RFA-AFSPEQ
Acceptability will be assessed using the self-designed Ring Fit Adventure Acceptability, Feasibility, Safety, and Participation Experience Questionnaire (RFA-AFSPEQ). Higher scores indicate greater acceptance of the intervention.
Time frame: Week 8
The 5-item Brief Symptom Rating Scale (BSRS-5)
It serves as an assessment of psychological distress and mental health status. Each item is evaluated using a 5-point Likert scale ranging from 0 ("not at all") to 4 ("extremely").
Time frame: Baseline, Week 8, Week 12, and Week 24
Change in heart rate
Heart rate will be measured in beats per minute (bpm) before and after each intervention session. For each session, the within-session change will be calculated as the post-session value minus the pre-session value. The reported value is the average of these within-session changes across the 8 weeks interven. Positive values indicate an increase in heart rate after the session.
Time frame: During the 8-week intervention period
Change in peripheral oxygen saturation
Peripheral oxygen saturation will be measured as a percentage (%) before and after each intervention session. The reported value will be the mean change from pre-session to post-session peripheral oxygen saturation during the 8-week intervention period.
Time frame: During the 8-week intervention period
Change in systolic blood pressure
Systolic blood pressure will be measured in mmHg before and after each intervention session. The reported value will be the mean change from pre-session to post-session systolic blood pressure during the 8-week intervention period.
Time frame: During the 8-week intervention period
Change in diastolic blood pressure
Diastolic blood pressure will be measured in mmHg before and after each intervention session. The reported value will be the mean change from pre-session to post-session diastolic blood pressure during the 8-week intervention period.
Time frame: During the 8-week intervention period
Plan to share: No — Individual participant data will not be shared because no data-sharing plan was established in the study protocol and informed consent process.
Started Jun 2026 (actual). Primary completion is estimated for Nov 2026, 5 months after the start.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Tungs' Taichung Metroharbour Hospital